| P2093 | author name string | J W Cohen Tervaert | |
| P2860 | cites work | Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma | Q81542034 |
| | CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C | Q81904105 |
| | The molecular mechanisms of the thrombotic complications of atherosclerosis | Q24656816 |
| | Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease | Q24675119 |
| | Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study | Q28139747 |
| | Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL | Q28365433 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | Nomenclature of systemic vasculitides. Proposal of an international consensus conference | Q29616304 |
| | Atherosclerosis. the road ahead | Q29618972 |
| | Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis | Q31120357 |
| | Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis. | Q33292085 |
| | The mortality of rheumatoid arthritis | Q34338843 |
| | Infections in primary vasculitides. | Q34709067 |
| | Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. | Q34858442 |
| | The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies | Q35084923 |
| | Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment | Q35179000 |
| | Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica | Q35548953 |
| | Accelerated atherosclerosis in patients with Wegener's granulomatosis | Q35555500 |
| | The role of myeloperoxidase in the pathogenesis of systemic vasculitis. | Q35636897 |
| | Atherosclerosis in Takayasu arteritis | Q35637850 |
| | Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis | Q35772969 |
| | Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis | Q35868276 |
| | SLE, atherosclerosis and cardiovascular disease | Q36135534 |
| | Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? | Q36247811 |
| | Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 |
| | Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis | Q36399030 |
| | Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid | Q36477710 |
| | Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis | Q36577503 |
| | Coronary involvement in Takayasu's arteritis | Q36940184 |
| | Mortality in established rheumatoid arthritis. | Q36942644 |
| | Autoimmunity in atherosclerosis: a protective response losing control? | Q37138017 |
| | Takayasu's arteritis | Q73101341 |
| | Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 |
| | Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease | Q73442157 |
| | Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients | Q73661498 |
| | Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis | Q73731133 |
| | Wegener's granulomatosis: clinical course in 108 patients with renal involvement | Q73789435 |
| | Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome | Q74376610 |
| | Carotid and femoral artery stiffness in Takayasu's arteritis. An ultrasound study | Q74442072 |
| | Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis | Q77402635 |
| | Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage | Q77411973 |
| | Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis | Q77417342 |
| | Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? | Q79850309 |
| | Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins | Q80373983 |
| | Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis | Q80373987 |
| | Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission | Q80388339 |
| | Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? | Q80908056 |
| | Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease | Q81139189 |
| | Regulatory T-cell immunity and its relevance to atherosclerosis | Q37138025 |
| | From vulnerable plaque to atherothrombosis. | Q37138032 |
| | Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus | Q37209364 |
| | Cardiovascular involvement in systemic autoimmune diseases | Q37279502 |
| | Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. | Q37421806 |
| | Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease | Q37421811 |
| | Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. | Q38479125 |
| | Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study | Q40196845 |
| | Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential | Q40636649 |
| | Cell adhesion molecules in vasculitis. | Q41436568 |
| | Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies | Q41631341 |
| | Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study | Q42421542 |
| | Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 |
| | Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis | Q42981202 |
| | Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions | Q43594553 |
| | The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 |
| | Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience | Q43738340 |
| | Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study | Q43846699 |
| | Role of C-C chemokines in Takayasu's arteritis disease | Q44233375 |
| | Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor | Q44288328 |
| | Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement | Q44358548 |
| | High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement | Q44625424 |
| | Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation | Q44810026 |
| | Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome. | Q45130672 |
| | -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis. | Q45969719 |
| | Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro | Q46419664 |
| | Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation | Q46433523 |
| | Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis | Q46505203 |
| | Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis | Q46578800 |
| | Atherosclerosis in patients with biopsy-proven giant cell arteritis | Q46873591 |
| | Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. | Q46881610 |
| | The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. | Q46964628 |
| | Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation | Q47209180 |
| | Has the prognosis for patients with pauci-immune necrotizing glomerulonephritis improved? | Q47776289 |
| | Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. | Q47917138 |
| | Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. | Q50922903 |
| | Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? | Q51464984 |
| | CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. | Q51962402 |
| | Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis. | Q51980086 |
| | Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. | Q52583321 |
| | Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study. | Q53756247 |
| | Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis. | Q54534749 |
| | Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis. | Q54607726 |
| | Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis | Q61914623 |
| | Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR −/− Mice | Q63917020 |
| | Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort | Q71076836 |
| | Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis | Q71115309 |
| | Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? | Q72998270 |
| | Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice | Q73054106 |
| P433 | issue | 3 | |
| P921 | main subject | immunology | Q101929 |
| | atherosclerosis | Q12252367 |
| P304 | page(s) | 377-385 | |
| P577 | publication date | 2009-03-20 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis | |
| P478 | volume | 156 | |